Generics:Sodium Chloride 0.9%%
These intravenous solutions are intended for use as supplies of electrolytes and water for hydration in adults and children. Extracellular fluid replenishment, therapy of metabolic alkalosis in the presence of fluid loss, and moderate sodium depletion are all indications for 0.9 percent sodium chloride infusion. The infusion of 0.9 percent sodium chloride is also approved for use as a priming solution in hemodialysis treatments, and it may be used to start and stop blood transfusions without hemolyzing red blood cells. Infusions of sodium chloride are also used as pharmaceutic aids and diluents for infusing suitable medication additions. Consult the prescription information that comes with the additional medicines.
The most abundant extracellular cation is sodium chloride. It replenishes sodium ions, which is necessary for electrolyte and fluid balance, osmotic pressure regulation, and water distribution. It is used as a source of electrolytes and water for hydration, metabolic acidosis therapy, haemodialysis priming solution, and hyperosmolar diabetic treatment. It's also utilized as a diluent for infusing medication additives that are compatible with it.
This solution is for intravenous use only. Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.
In the average adult, daily requirements of sodium and chloride are met by the infusion of one liter of 0.9% sodium chloride (154 mEq each of sodium and chloride). There is no specific pediatric dose. The dose is dependent on weight, clinical condition and laboratory results. Follow recommendations of appropriate pediatric reference text. Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient. 0.9% Sodium Chloride Injection may also be administered intravascularly as a priming fluid in hemodialysis procedures.
When Sodium Chloride Injection is used as a diluent for infusion of compatible drug additive, refer to dosage and administration information accompanying additive drugs. Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Where the administration of salt or chloride might cause clinical harm, this solution is contraindicated.
Fever, infection at the injection site, venous thrombosis or phlebitis spreading from the injection site, extravasation, and hypervolemia are all reactions that might occur as a result of the solution or the delivery strategy. The doctor should also be aware of the risk of medication additives causing unpleasant reactions. It's a good idea to look up the prescribing information for any medication additives that will be used in this way. Symptoms may arise as a result of an excess or deficit of one or more of the ions present in the solution; thus, electrolyte levels must be monitored often.Due to the retention of water, hypernatremia can cause edema and aggravation of congestive heart failure, resulting in an increased extracellular fluid volume. Chloride ions may induce a loss of bicarbonate ions when injected in significant numbers, resulting in an acidifying effect. If an adverse response occurs, stop the infusion, assess the patient, implement appropriate treatment countermeasures, and preserve the remaining fluid for analysis if needed.
Pregnancy Classification C. Sodium Chloride Injection has not been used in animal reproductive research. It's also unclear whether Sodium Chloride Injection can harm a fetus or alter reproductive capacity when given to a pregnant woman. Only administer Sodium Chloride Injection to a pregnant lady if it is absolutely necessary.
Mothers who are breastfeeding: This medication is not known to be excreted in human milk. Because many medications are excreted in human milk, when Sodium Chloride Injection USP is given to a breastfeeding woman, caution should be used.
During extended parenteral treatment or anytime the patient's condition justifies it, clinical examination and periodic laboratory findings are required to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance. In these or other solutions, significant variations from normal concentrations may necessitate modification of the electrolyte pattern. In patients with hypervolemia, renal insufficiency, urinary tract blockage, or imminent or severe cardiac decompensation, this solution should be administered with caution.
Extraordinary electrolyte losses, such as those caused by prolonged nasogastric suction, vomiting, diarrhea, or the drainage of a gastrointestinal fistula, may need extra electrolyte replacement. As needed, more electrolytes, minerals, and vitamins should be provided.
Patients using corticosteroids or corticotropin, as well as other salt-retaining patients, should avoid sodium-containing fluids. Patients with renal or cardiovascular insufficiency, with or without congestive heart failure, should be given sodium-containing solutions with caution, especially if they are postoperative or elderly.
A daily infusion of more than one liter of isotonic (0.9 percent) sodium chloride may provide more sodium and chloride than typically present in blood, exceeding normal tolerance and leading in hypernatremia; this may also result in a loss of bicarbonate ions, resulting in an acidifying impact. To reduce the possibility of incompatibilities caused by combining this solution with additional additives that may be prescribed, the final infusate should be examined for cloudiness or precipitation immediately after mixing, before to administration, and at regular intervals during administration.
In a series connection, do not use a plastic container. If the administration is regulated by a pumping device, it is critical to stop the pumping activity before the container gets dry, as this might cause an air embolism. This solution should be administered intravenously with sterilized equipment. At least once every 24 hours, the IV administration equipment should be changed.
Keep away from light and heat in a dry area. Keep out of children's reach.
Salpac - IV 100 ml
Disclaimer:The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website/ app.